Campbell & CO Investment Adviser LLC Regenxbio Inc. Transaction History

Campbell & CO Investment Adviser LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$12.17 - $24.61 $221,932 - $448,787	18,236 Added 115.38%	34,041 $717,000
Q4 2023 Feb 13, 2024	BUY	$12.89 - $20.82 $203,726 - $329,060	15,805 New	15,805 $283,000
Q3 2022 Nov 14, 2022	BUY	$22.29 - $35.04 $515,902 - $811,000	23,145 New	23,145 $612,000
Q4 2018 Feb 08, 2019	SELL	$39.11 - $75.15 $109,508 - $210,420	-2,800 Closed	0 $0
Q3 2018 Nov 08, 2018	BUY	$65.0 - $82.15 $182,000 - $230,020	2,800 New	2,800 $211,000

196

43M

104K

478K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $329M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.